Riskpilot← Back to searchSign inGet full accessHP HALDEN PHARMA AS
ASActiveOrg 931241818Svinesundsveien 80, 1788 HaldenManufacture of pharmaceutical preparations · NACE 2120Est. 2023693 employees
Revenue 2024
NOK 1,3B
EBITDA margin
6.2%
Equity ratio
7.1%
Financial strength
Net profit 2024
NOK 47,8M
693 employees
| Revenue | NOK 1,3B | — |
| EBITDA | NOK 78,4M | — |
| Net profit | NOK 47,8M | — |
| Total assets | NOK 815,2M | +7956% |
| Equity | NOK 57,8M | +478% |
| Employees | 693 | — |
Legal name
HP HALDEN PHARMA AS
Org number
931241818
Legal form
Aksjeselskap
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
20. april 2023
Share capital
NOK 7 830 000
Employees
693 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Ian thomas cooper
Company purpose
Produksjon og salg av legemidler, parenteral og medisinsk infusjons- og ernæringsterapi og lignende produkter og relatert virksomhet, samt å yte konsulenttjenester, forvaltning av egne eiendeler og erverv og forvaltning av aksjeposter i selskaper innen helse og farmasøytisk virksomhet.
Address
Svinesundsveien 80, 1788 Halden
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 0 | 1 262 241 |
| Staff expenses | −0 | −409 584 |
| EBITDA | 0 | 78 400 |
| Depreciation & amort. | −0 | −2 093 |
| EBIT | 0 | 76 307 |
| Net financials | 0 | −14 927 |
| Profit before tax | 0 | 61 380 |
| Tax | −0 | 13 547 |
| Net profit | 0 | 47 833 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 10 119 | 815 206 |
| Equity | 10 000 | 57 833 |
| Long-term debt | 0 | 366 843 |
| Short-term debt | 119 | 384 607 |
| Total debt | 119 | 751 450 |
EBITDA margin
6.2%
This company
15.8%
Market median
-61% vs market
20232024
Equity ratio
7.1%
This company
38.2%
Market median
-81% vs market
20232024
Return on equity
82.7%
This company
18.4%
Market median
+349% vs market
20232024
Net profit margin
3.8%
This company
8.1%
Market median
-53% vs market
20232024
Asset turnover
1.55×
This company
1.12×
Market median
+38% vs market
20232024
Debt / equity
13.10×
This company
0.62×
Market median
-2013% vs market
20232024
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
FR Deputy Member | Deputy Member | 2024 |
CL Deputy Member | Deputy Member | 2024 |
VR Deputy Member | Deputy Member | 2024 |
AA Deputy Member | Deputy Member | 2024 |
SM Chief Executive Officer | Chief Executive Officer | 2023 |
VM Deputy Member | Deputy Member | 2024 |
| Former (1) | ||
VR Deputy Member | Deputy Member | 2024 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (7) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2024 | |
| Chairman | 2023 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2025 | |
| Former (2) | ||
| Board of Directors | 2024 – 2025 | |
| Chairman | 2023 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Selskap Prange Pharma Gmbh | Company | 100% | 100% | 2023 |
Prange Pharma Gmbh | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HP HALDEN PHARMA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Frank Roger Los | Deputy Member | 0 companies |
| Christine Louise Thorvik Østensvig | Deputy Member | 0 companies |
| Vibeke Røstengen-Selldin | Deputy Member | 0 companies |
| Amru Al Hashimi | Deputy Member | 0 companies |
| Sebastian Marcus Heckerodt | Chief Executive Officer | 0 companies |
| Veslemøy Minge Engh | Deputy Member | 0 companies |
| Vibeke Røstengen | Deputy Member | 0 companies |
| Anja Semmler | Board of Directors | 0 companies |
| Tore Andreas Brevig | Board of Directors | 0 companies |
| Otto Prange | Chairman | 0 companies |
| Siw-Hege Christiansen | Board of Directors | 0 companies |
| Albrecht Heinrich Brodhun | Board of Directors | 0 companies |
| Hans-Christian Donjem | Chairman | 0 companies |
| Tone Janikke Gummesen Thon | Board of Directors | 0 companies |
| Dietmar Rohleder | Board of Directors | 0 companies |
| Bettina Fuderholz | Board of Directors | 0 companies |